DOW
30
2
RIG
44
-2
GOOG
69
-10
BMY
61
-3
HES
66
3
AVGO
35
-2
BK
72
-2
EQT
57
-3
NTAP
61
-3
CHD
48
-3
AMAT
43
-5
WHR
70
4
CVX
38
6
FOX
57
-3
KEY
46
-2
PM
58
2
TROW
51
-2
LB
63
-4
LEG
31
3
CF
53
2
DOW
30
2
RIG
44
-2
GOOG
69
-10
BMY
61
-3
HES
66
3
AVGO
35
-2
BK
72
-2
EQT
57
-3
NTAP
61
-3
CHD
48
-3
AMAT
43
-5
WHR
70
4
CVX
38
6
FOX
57
-3
KEY
46
-2
PM
58
2
TROW
51
-2
LB
63
-4
LEG
31
3
CF
53
2
Financhill
Back

First Trust Commercial Mortg Opports ETF Vs. Dyne Therapeutics Industry Stock Comparison

Sell
22

CAAA
First Trust Commercial Mortg Opports ETF

Last Price:
20.29
Seasonality Move:
--
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
22
First Trust Commercial Mortg Opports ETF (CAAA) is a Sell

Is First Trust Commercial Mortg Opports ETF a Buy, Sell or Hold?

  • The current First Trust Commercial Mortg Opports ETF [CAAA] share price is $20.24. The Score for CAAA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • CAAA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CAAA Stock Price Chart

What is First Trust Commercial Mortg Opports ETF's stock price today?

  • The First Trust Commercial Mortg Opports ETF share price today is $20.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAAA is experiencing selling pressure, which indicates risk of future bearish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $34.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

CAAA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.21 Sell
Chaikin Money Flow: -388 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.22 - 20.44) Sell
Bollinger Bands (100): (20.26 - 20.66) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 60.64 Buy
Chaikin Money Flow: 1192325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CAAA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.24 Sell
20-day SMA: 20.29 Sell
50-day SMA: 20.52 Sell
200-day SMA: 0 Buy
8-day EMA: 20.24 Buy
20-day EMA: 20.3 Sell
50-day EMA: 20.41 Sell
200-day EMA: 2.82 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Buy
20-day SMA: 30.81 Buy
50-day SMA: 32.62 Buy
200-day SMA: 32.06 Buy
8-day EMA: 30.24 Buy
20-day EMA: 30.74 Buy
50-day EMA: 32.95 Buy
200-day EMA: 30.83 Buy

First Trust Commercial Mortg Opports ETF Earnings Growth & CAAA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

First Trust Commercial Mortg Opports ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):